These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26142564)

  • 41. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
    Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
    Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on nicotine versus cocaine self-administration and relapse in squirrel monkeys.
    Justinova Z; Le Foll B; Redhi GH; Markou A; Goldberg SR
    Psychopharmacology (Berl); 2016 May; 233(10):1791-800. PubMed ID: 26149611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rats with extended access to cocaine exhibit increased stress reactivity and sensitivity to the anxiolytic-like effects of the mGluR 2/3 agonist LY379268 during abstinence.
    Aujla H; Martin-Fardon R; Weiss F
    Neuropsychopharmacology; 2008 Jul; 33(8):1818-26. PubMed ID: 17895914
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigating the role of mGluR2 versus mGluR3 in antipsychotic-like effects, sleep-wake architecture and network oscillatory activity using novel Han Wistar rats lacking mGluR2 expression.
    Wood CM; Wafford KA; McCarthy AP; Hewes N; Shanks E; Lodge D; Robinson ESJ
    Neuropharmacology; 2018 Sep; 140():246-259. PubMed ID: 30005976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking.
    Bossert JM; Busch RF; Gray SM
    Neuroreport; 2005 Jun; 16(9):1013-6. PubMed ID: 15931079
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-acetylaspartylglutamate Inhibits Heroin Self-Administration and Heroin-Seeking Behaviors Induced by Cue or Priming in Rats.
    Zhu H; Lai M; Chen W; Mei D; Zhang F; Liu H; Zhou W
    Neurosci Bull; 2017 Aug; 33(4):396-404. PubMed ID: 28534263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The role of varenicline on alcohol-primed self-administration and seeking behavior in rats.
    Randall PA; Jaramillo AA; Frisbee S; Besheer J
    Psychopharmacology (Berl); 2015 Jul; 232(14):2443-54. PubMed ID: 25656746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495.
    Linden AM; Johnson BG; Trokovic N; Korpi ER; Schoepp DD
    Neuropharmacology; 2009 Aug; 57(2):172-82. PubMed ID: 19477188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Group II mGluRs modulate baseline and arthritis pain-related synaptic transmission in the rat medial prefrontal cortex.
    Kiritoshi T; Neugebauer V
    Neuropharmacology; 2015 Aug; 95():388-94. PubMed ID: 25912637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic social instability increases anxiety-like behavior and ethanol preference in male Long Evans rats.
    Roeckner AR; Bowling A; Butler TR
    Physiol Behav; 2017 May; 173():179-187. PubMed ID: 28202350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation of group II metabotropic glutamate receptors attenuates both stress and cue-induced ethanol-seeking and modulates c-fos expression in the hippocampus and amygdala.
    Zhao Y; Dayas CV; Aujla H; Baptista MA; Martin-Fardon R; Weiss F
    J Neurosci; 2006 Sep; 26(39):9967-74. PubMed ID: 17005860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered object exploration but not temporal order memory retrieval in an object recognition test following treatment of rats with the group II metabotropic glutamate receptor agonist LY379268.
    Lins BR; Ballendine SA; Howland JG
    Neurosci Lett; 2014 Feb; 560():41-5. PubMed ID: 24361135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of Akt and Wnt signaling by the group II metabotropic glutamate receptor antagonist LY341495 and agonist LY379268.
    Sutton LP; Rushlow WJ
    J Neurochem; 2011 Jun; 117(6):973-83. PubMed ID: 21477044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analgesic effects of the selective group II (mGlu2/3) metabotropic glutamate receptor agonists LY379268 and LY389795 in persistent and inflammatory pain models after acute and repeated dosing.
    Jones CK; Eberle EL; Peters SC; Monn JA; Shannon HE
    Neuropharmacology; 2005; 49 Suppl 1():206-18. PubMed ID: 15998527
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β.
    Xing B; Han G; Wang MJ; Snyder MA; Gao WJ
    Neuropharmacology; 2018 Jul; 137():359-371. PubMed ID: 29793154
    [TBL] [Abstract][Full Text] [Related]  

  • 56. mGlu
    Tyler RE; Van Voorhies K; Blough BE; Landavazo A; Besheer J
    Pharmacol Biochem Behav; 2024 Jun; 239():173767. PubMed ID: 38608960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. mGluR2/3 mediates short-term control of nicotine-seeking by acute systemic N-acetylcysteine.
    Moro F; Orrù A; Marzo CM; Di Clemente A; Cervo L
    Addict Biol; 2018 Jan; 23(1):28-40. PubMed ID: 27558879
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain ethanol concentrations and ethanol discrimination in rats: effects of dose and time.
    Quertemont E; Green HL; Grant KA
    Psychopharmacology (Berl); 2003 Jul; 168(3):262-70. PubMed ID: 12684735
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modulation of stress-induced and stimulated hyperprolactinemia with the group II metabotropic glutamate receptor selective agonist, LY379268.
    Johnson MP; Chamberlain M
    Neuropharmacology; 2002 Oct; 43(5):799-808. PubMed ID: 12384165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discriminative stimulus effects of self-administered ethanol.
    Shelton KL; Macenski MJ
    Behav Pharmacol; 1998 Jul; 9(4):329-36. PubMed ID: 10065921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.